Rating History for Kymera Therapeutics (KYMR) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for KYMR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/25/2026 Biren Amin New Coverage Overweight
(N/A)		 N/A
(N/A)		 91.01
(98.25)		 7.96% Details